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Abstract: Paecilomyces lilacinus is a ubiquitous saprophytic fungus that rarely causes infections in humans, frequently 
affecting the eyes and the skin. Cutaneous and subcutaneous infections mainly occur in immunocompromised hosts but 
have occasionally been reported in immunocompetent patients. The clinical spectrum is highly heterogeneous and 
diagnosis is often delayed. 
A 60-year-old woman with idiopathic chronic necrotizing vasculitis treated since 10 years with a series of 
immunosuppressive therapies presented since three years various clinical presentations of chronic hyalohyphomycosis 
caused by P. lilacinus. Diagnosis was only obtained three years after the first clinical signs, following the histologic 
analysis of the surgical excision of a cutaneous abscess. Treatment with oral voriconazole was successful. 
This case report illustrates the highly heterogeneous clinical aspects of hyalohyphomycosis by P. lilacinus leading to a 
delay in diagnosis and treatment, particularly in the immunosuppressed patient. 
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INTRODUCTION 
 Hyalohyphomycosis is a rare infection caused by fungi 
that produce hyaline septate hyphae in tissues [1]. 
Etiological agents include, among others, species of 
Acremonium, Fusarium, Scopulariopsis, Paecilomyces and 
Beauveria. The genus Paecilomyces was identified for the 
first time in 1907 [2]. P. lilacinus has only been assigned 
since 1974 to the genus Paecilomyces [3]. The lilac-colored 
colony and the production of a deep purplish-red pigment on 
Czapek solution agar are characteristic. P. lilacinus and P. 
variotii are the two major species, which are most frequently 
associated with infections in human. Most of these occur in 
immunocompromised hosts, while the incidence in 
immunocompetent hosts is also increasing [4]. Paecilomyces 
species are rare but emerging causes of hyalohyphomycosis. 
These fungi are regularly isolated from soil and air, decaying 
plants and food products [1]. Their potential resistance to 
sterilization techniques increases their clinical significance. 
Paecilomyces infections usually concern oculomycosis as 
well as cutaneous and subcutaneous infections [1], and 
occasionally sinusitis, fungaemia, onychomycosis, lung 
abscess, pleural effusion, osteomyelitis, peritonitis and 
endocarditis. 
 Cutaneous and subcutaneous infections have been 
reported to be highly heterogeneous and may be notoriously 
difficult to diagnose. Herein, the polymorphous clinical and 
histologic features of chronic cutaneous hyalohyphomycosis 
related to P. lilacinus are illustrated in a patient with 
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longstanding immunosuppressive therapies for idiopathic 
necrotizing vasculitis. 
CASE REPORT 
 A 60-year-old woman presented a tender and 
asymptomatic swelling, 5 cm in diameter, at the posterior 
aspect of her left arm (Fig. 1). According to the patient, she 
had this swelling for over 12 months. The lesion appeared 
progressively and increased in size over time. The lesion was 
mistaken clinically as a lipoma and echographically as a 
hematic collection and no treatment was initiated. The 
patient also noticed the development of three subcutaneous 
nodular and pustular lesions in the immediate vicinity of the 
swelling during the last few weeks (Fig. 2). Furthermore, she 
complained of an erythematous-violaceous irregularly 
shaped infiltrated large plaque of the entire anterolateral 
aspect of her left thigh (Fig. 3). This lesion was also present 
since more than three years and several punch and excisional 
biopsies were performed without however evidencing the 
presence of fungal agents despite periodic acid-Schiff (PAS) 
and Gomori-Grocott histochemical stainings. She denied any 
trauma related to these areas and had no systemic 
complaints. She was a febrile and without palpable regional 
lymph nodes. 
 The patient had been followed for over 10 years in the 
rheumatology department for anecrotizing vasculitis. 
Extensive and repetitive workups remained negative 
(antinuclear antibodies, p and cANCA’s cryoglobulines, 
anti-phospholipids, etc) and the vasculitis was classified as 
idiopathic. Over time, she received several lines of 
immunosuppressive therapies: cyclophosphamide, rituximab 
IV (anti-CD20 monoclonal antibodies), azathioprine and 
systemic corticosteroids. The cutaneous lesions of her 
idiopathic necrotizing vasculitis occurred most of the times 
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on her legs. Every time noticing a new lesion in the lower 
extremities, the rheumatologist suspected a recurrence of 
vasculitis and treated the patient with systemic cortico-
steroids. Current medication included methylprednisolone 12 
mg daily, azathioprine 50mg tid, esomeprazol 40 mg daily, 
calcium carbonate 1250mg daily and vitamin D 100.000UI 
weekly. On physical examination, blood pressure was 
140/90mmHg, respiratory rate was 18 breaths/min and pulse 
rate 100/min with a regular rhythm. All laboratory work 
including a complete blood count, chemistry and liver panel 
was in normal range. 
 
Fig. (1). Cutaneous Paecilomyces lilacinus infection onthe left arm 
characterized bya large and tender swelling. 
 
Fig. (2). Cutaneous nodular lesions by Paecilomyces lilacinus on 
the left arm. 
 
Fig. (3). Chronic cutaneous Paecilomyces lilacinus infection on left 
thigh characterized byan erythematous-violaceous, partially 
necrotic and infiltrated plaque. 
 Due to the longstanding administration of azathioprine 
and her fair phototype, the patient had already presented 
several squamous cell carcinomas (SCC). She presented with 
a clinical suspicion of three new SCC’s on her left upper 
arm. Surgical excision was decided and simultaneously she 
requested the excision of the large swelling on the anterior 
aspect of her left upper arm. On excision, a large amount of 
pustular secretions was evidenced requiring the insertion of a 
drain. Histology of the biopsy specimens revealed a heavily 
necrotic and granulomatous reaction with giant cells and few 
inflammatory cells in the dermis on haematoxylin/eosin 
staining (Fig. 4). PAS (Fig. 5) and Gomori-Grocott 
methenamine-silver (Fig. 6) histochemical stainings noted 
the presence of hyaline hyphae within the dermal necrotic 
tissue with numerous septate hyphae associated with the 
presence of spores. Giemsa staining was negative. The final 
histologic result was a hyalohyphomycosis. Bacterial 
cultures of the fluid were negative. Fungal culture, however, 
grew a mold, which was subsequently identified as P. 
lilacinus after a subculture on an enriched medium. Fungal 
cultures of blood presented no growth. Although no 
 
 
Fig. (4). Granulomatous and necrotic infiltration of the entire 
reticular dermis (H/E, x 4). 
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breakpoints have been established for molds, antifungal 
susceptibility showed an elevated minimum inhibitory 
concentration (MIC) for amphotericin B (MIC >32µg/ml) 
and itraconazole (MIC >32µg/ml). However, a low MIC for 
voriconazole (MIC =0,094µg/ml) was noted. Therefore, a 
treatment with oral voriconazole was initiated. The loading 
dose was 300mg bid on the first day, followed by 200mg 
bid, prescribed for a period of 3 months. During the first 4 
weeks of treatment, clinical resolution progressed nicely in 
the left thigh and the scar of the surgery performed in the left 
arm was healthy. The patient suffered no major side effects 
related to the treatment except for a slight elevation of liver 
enzymes. Unfortunately, the patient died during the fifth 
week of treatment from a bacterial pneumonia. 
 
Fig. (5). Demonstration of septate hyphae in red (PAS, x40). 
 
Fig. (6). Grocott-Gomori methenamine-silver staining of a biopsy 
specimen showing regular filamentous fungi and spores. 
DISCUSSION 
 In most of the infections caused by these environmental 
fungi, some predisposing factors were found. As to 
cutaneous and subcutaneous P. lilacinus infections, risk 
factors were mainly solid organ and bone marrow 
transplantation, malignancies, corticosteroid therapy, 
primary immunodeficiency, diabetes mellitus and AIDS [1]. 
Our patient presented a chronic and severe iatrogenic 
immunosuppression following several immunosuppressive 
regimens used for over 10 years to treat her necrotizing 
vasculitis. The portal of entry attributed to this fungus 
usually involves a breakdown of the skin barrier, in dwelling 
catheters or inhalation. There was no evidence of 
hematogenous spread in our patient and fungal blood 
cultures were negative. We hypothesized that our patient was 
contaminated by direct inoculation through an unnoticed, 
minor skin abrasion, facilitated by a highly atrophic skin 
induced by chronic systemic corticosteroids [5]. 
 Cutaneous and subcutaneous infections present numerous 
clinical manifestations such as solitary or disseminated skin 
eruptions with erythematous macules, papules, vesicles, or 
nodules with a necrotic center [1]. Our patient presented 
several clinical presentations such as nodular lesions and a 
swelling of the arm, as well as a large, irregular, infiltrated 
and indurated plaque on the thigh. As illustrated in our case, 
these highly polymorphous clinical images frequently lead to 
a delay in diagnosis subsequently interfering with adequate 
treatment. 
 Fungal culture and histology of the lesions are required to 
diagnose a P. lilacinus infection. Even if histological 
examination can identify fungal structures, the fungal culture 
remains the gold standard for fungal identification. 
Paecilomyces molds grow fast on Sabouraud dextrose agar 
and the pathogen can be identified within one to two weeks 
[6]. 
 Because of their different antifungal susceptibilities, the 
differentiation between Paecilomyces species is mandatory 
to treat the disease correctly. P. lilacinus has a high resist-
nce to conventional antifungal drugs unlike P. variotii, 
which has a greater susceptibility to these agents [7]. Given 
P. lilacinus’ broad resistance, it is always useful to realize a 
susceptibility test in order to define the most appropriate 
treatment. In vitro studies of P. lilacinus antifungal 
susceptibility have shown poor activity of older antifungal 
drugs (amphotericin B, flucytosine and fluconazole) and 
contradiction exists concerning data regarding the activity of 
the first-generation azoles, such as ketoconazole, 
miconazole, clotrimazole and itraconazole [7]. The second-
generation triazoles, such as voriconazole, posaconazole and 
ravuconazole present a good antifungal effect [8]. More 
specifically, the last two drugs show very low MICs 
although no data have been published concerning their 
clinical use. Currently, there is no standard treatment 
regimen for P. lilacinus infections. Although the clinical 
experience with voriconazole is limited, it is recommended 
as first-line therapy [9]. Up to date, only seven published 
cases of skin infection treated with voriconazole, which were 
all successful. Although we were unable to follow the entire 
evolution of the lesions, a spectacular regression was 
observed during the first 4 weeks with voriconazole 
treatment. 
 Treatment duration with voriconazole remains 
undetermined, ranging from 3 weeks to 10 months [10,11]. 
The treatment duration should rely on the clinical resolution 
of the infection and/or the presence of adverse effects linked 
to the medication. The most common adverse effects of 
voriconazole included visual disturbances, increased levels 
of hepatic enzymes and skin rash through photosensitization 
[12]. Surgical excision should also be considered on a case-
by-case basis. 
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 In conclusion, this case illustrates the highly 
polymorphous spectrum of P. lilacinus skin infection. 
Performing susceptibility tests is mandatory as resistance is 
not uncommon. Surgery should not be overlooked as 
treatment option. 
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